
Amicross 250mg Injection
Marketer
Medicross Pharmaceuticals
Salt Composition
Amikacin (250mg)
Overview Amicross 250mg Injection
Cefuroxime 250mg Injection is a broad-spectrum antibiotic combating diverse bacterial infections. These encompass urinary tract, bone, joint, lung (such as pneumonia), brain, and bloodstream infections, among others. Prophylactic use in hospitalized patients is also indicated. Cefuroxime 250mg Injection inhibits bacterial proliferation. Administered intravenously (IV drip) or intramuscularly by a healthcare professional only, self-injection is strictly prohibited. Adherence to the prescribed dosage schedule, at evenly spaced intervals, is crucial. Complete the entire course, even with symptom improvement; premature discontinuation risks relapse or exacerbation. Common adverse effects include injection site reactions and elevated blood urea nitrogen. Persistent side effects or treatment ineffectiveness warrant immediate medical consultation. High doses may induce vertigo, nephrotoxicity, and ototoxicity. Strict adherence to physician instructions is essential, potentially including regular monitoring of renal function, hearing acuity, and urinalysis. This antibiotic is contraindicated in pregnancy. Disclose pregnancy, pregnancy intentions, or breastfeeding to your doctor.
Uses of Amicross 250mg Injection
Infections caused by bacteria
Major Benefits of Amicross 250mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Amicross 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Amicross 250mg Injection:
Administering this medication will be done by your healthcare provider. Self-medication is strictly prohibited.
How Amicross 250mg Injection works:
Amicross 250mg Injection is a bacterial growth inhibitor, acting as an antibiotic by disrupting the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Amicross 250mg Injection presents no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Amicross 250mg Injection during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem the potential benefits outweigh the risks and prescribe it. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Amicross 250mg Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
The administration of Amicross 250mg Injection can potentially reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCAUTION
Individuals with kidney impairment should use Amicross 250mg Injection cautiously. Amicross 250mg Injection dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Amicross 250mg Injection in individuals with hepatic impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary. Physician consultation is advised.
What if you forget to take Amicross 250mg Injection :
Omit a dose of Amicross 250mg Injection? Seek your physician's advice.
Facts to Know About Amicross 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
| Action Class | Aminoglycoside antibiotics |
